| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1046/J.1468-2982.2000.00149.X |
| P698 | PubMed publication ID | 11304021 |
| P2093 | author name string | S D Silberstein | |
| D C McCrory | |||
| P2860 | cites work | Psychotomimesis mediated by kappa opiate receptors | Q28287612 |
| The cortical representation of pain | Q33539204 | ||
| Enhancement of opiate analgesia by nimodipine in cancer patients chronically treated with morphine: a preliminary report | Q34326398 | ||
| Ketorolac versus meperidine and hydroxyzine in the treatment of acute migraine headache: a randomized, prospective, double-blind trial | Q39235777 | ||
| Comparison of butorphanol nasal spray and fiorinal with codeine in the treatment of migraine | Q39372612 | ||
| Comparison of dihydroergotamine with metoclopramide versus meperidine with promethazine in the treatment of acute migraine | Q39475012 | ||
| Ketorolac versus meperidine-plus-promethazine treatment of migraine headache: evaluations by patients | Q39476698 | ||
| Transnasal butorphanol in the treatment of acute migraine | Q39477625 | ||
| A randomized, double-blind, comparative study of the efficacy of ketorolac tromethamine versus meperidine in the treatment of severe migraine | Q39500476 | ||
| Methotrimeprazine versus meperidine and dimenhydrinate in the treatment of severe migraine: a randomized, controlled trial. | Q39506318 | ||
| A Comparative Trial of Ergotamine Tartrate, Acetyl Salicylic Acid and a Dextropropoxyphene Compound in Acute Migraine Attacks | Q40889366 | ||
| Principles of opioid pharmacotherapy: practical implications of basic mechanisms | Q40990130 | ||
| The nature of opioid responsiveness and its implications for neuropathic pain: new hypotheses derived from studies of opioid infusions | Q41138419 | ||
| Functional analysis of cloned opioid receptors in transfected cell lines. | Q41153532 | ||
| Opioids in headache treatment. Is there a role? | Q41371899 | ||
| Pharmacology and mechanisms of opioid analgesic activity | Q41374982 | ||
| Current emergency treatment of severe migraine headaches | Q42065884 | ||
| Mu-opioids activate phospholipase C in SH-SY5Y human neuroblastoma cells via calcium-channel opening. | Q42165827 | ||
| Endogenous morphine and related opiates, a new class of chemical messengers | Q43072263 | ||
| Supraspinal mu 2-opioid receptors mediate spinal/supraspinal morphine synergy | Q44331828 | ||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | opioid | Q427523 |
| P304 | page(s) | 854-64; discussion 851-3 | |
| P577 | publication date | 2000-12-01 | |
| P1433 | published in | Cephalalgia | Q5063251 |
| P1476 | title | Opioids. | |
| P478 | volume | 20 |
| Q43263548 | Characterization of opioid receptors that modulate nociceptive neurotransmission in the trigeminocervical complex |
| Q44346107 | Clinician beliefs about opioid use and barriers in chronic nonmalignant pain |
| Q37610198 | Current and emerging treatment options for migraine and other primary headache disorders |
| Q44350090 | Micro-opioid receptor preferentially inhibits oxytocin release from neurohypophysial terminals by blocking R-type Ca2+ channels. |
| Q79890177 | Migraine |
| Q43725572 | Opioid chronopharmacology |
| Q44332661 | Opioid use and dependence among persons with migraine: results of the AMPP study |
| Q34551627 | Practical considerations for the treatment of elderly patients with migraine |
Search more.